Cong Chen, Zuliang Liu, Liguo Liu, Yan Xiao, et al. Broad neutralizing activity of a human monoclonal antibody against H7N9 strains from 2013 to 2017. Emerging Microbes & Infections vol 7, 179 (2018)
H7N9 influenza virus has been circulating among humans for five epidemic waves since it was first isolated in 2013 in China. The recent increase in H7N9 infections during the fifth outbreak in China has caused concerns of a possible pandemic. In this study, we describe a previously characterized human monoclonal antibody, HNIgGA6, obtained by isolating rearranged heavy-chain and light-chain genes from patients who had recovered from H7N9 infections. HNIgGA6 recognized multiple HAs and neutralized the infectivity of 11 out of the 12 H7N9 strains tested, as well as three emerging HPAI H7N9 isolates. The only resistant strain was A/Shanghai/1/2013 (H7N9-SH1), which carries the avian receptor alleles 186V and 226Q in the sialic acid-binding pocket. The mAb broadly neutralized divergent H7N9 strains from 2013 to 2017 and represents a potential alternative treatment for H7N9 interventions.
See Also:
Latest articles in those days:
- Phylogeography and gene pool analysis of highly pathogenic avian influenza H5N1 viruses reported in India from 2006 to 2021 16 hours ago
- Analysis of a diffusive epidemic model with a zero-infection zone 17 hours ago
- Quick detection of H5N1 avian influenza virus by surface enhanced Raman scattering(SERS) using aptamer capture 17 hours ago
- The critical role of RAGE in severe influenza infection: A target for control of inflammatory response in the disease 18 hours ago
- Human infection caused by avian influenza A (H10N5) virus 18 hours ago
[Go Top] [Close Window]